by Richard A. Hendricks | Jun 7, 2021 | Health News
The study included 257 patients with early symptomatic Alzheimer’s disease; 131 received donanemab, while 126 received a placebo. The researchers found donanemab slowed the decline of cognition and daily function in Alzheimer’s patients by 32% after 76 weeks, compared to those who received a placebo. Taken over 18 months, that 32% slowing of decline could […]
by Richard A. Hendricks | Feb 12, 2021 | Health News
The preliminary results came from the RECOVERY trial, which has been testing potential Covid-19 treatments since March 2020. Tocilizumab was added to the trial in April 2020. The results were shared in a preprint, but have not yet been peer-reviewed or published in a...
by Richard A. Hendricks | Sep 28, 2020 | Health News
“Before Covid, I was a 59-year-old, relatively healthy man,” said the broadband technician from Denver. “If I had to say where I’m at now, I’d say about 50% of where I was, but when I first went home, I was at 20%.” He credits much...
by Richard A. Hendricks | Sep 25, 2020 | Health News
The updated FDA guidance said the filling material could lead to health issues for those with a hypersensitivity to mercury. Dental amalgam fillings are a mixture of silver, tin, copper and mercury. The FDA and American Dental Association have said for years the...
by Richard A. Hendricks | Sep 13, 2020 | Health News
Gahan, a clinical psychologist in Shrewsbury, United Kingdom, hasn’t been able to return to work. The disease causes what she calls “storms,” disabling periods when she feels shortness of breath, numbness in her hands and feet and her heart rate...
